Evidence map›Paper›PMID 36448709›Full record

ArticleACS applied materials & interfaces2022

Development and Characterization of Bioinspired Lipid Raft Nanovesicles for Therapeutic Applications.

Lalithasri Ramasubramanian, Harsha Jyothi, Leora Goldbloom-Helzner, Brandon M Light, Priyadarsini Kumar, Randy P Carney, Diana L Farmer, Aijun Wang

Open access · hybridAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Engineering of Cell Derived-Nanovesicle as an Alternative to Exosome Therapy.Tissue engineering and regenerative medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lalithasri RamasubramanianDepartment of Surgery, School of Medicine, University of California-Davis, Sacramento, California 95817, United States.
Harsha JyothiDepartment of Surgery, School of Medicine, University of California-Davis, Sacramento, California 95817, United States.
Leora Goldbloom-HelznerDepartment of Surgery, School of Medicine, University of California-Davis, Sacramento, California 95817, United States.
Brandon M LightDepartment of Surgery, School of Medicine, University of California-Davis, Sacramento, California 95817, United States.
Priyadarsini KumarDepartment of Surgery, School of Medicine, University of California-Davis, Sacramento, California 95817, United States.
Randy P CarneyDepartment of Biomedical Engineering, University of California-Davis, Davis, California 95616, United States.ORCID 0000-0001-8193-1664
Diana L FarmerDepartment of Surgery, School of Medicine, University of California-Davis, Sacramento, California 95817, United States.ORCID 0000-0002-3530-5993
Aijun WangDepartment of Surgery, School of Medicine, University of California-Davis, Sacramento, California 95817, United States.ORCID 0000-0002-2985-3627
Shriners Hospitals for Children · USUniversity of California, Davis · US

Funding

Engineered Neuroprotective Stem-Cell Exosomes for In Utero Spina Bifida TherapyR01NS115860 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FARMER, DIANA LEE, WANG, AIJUN · 2020 to 2024
$2.5M
Fetal Tissue Engineering to Treat Spina Bifida Before BirthR01NS100761 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI WANG, AIJUN · 2017 to 2021
$1.7M
NINDS NIH HHS R01 NS100761NINDS NIH HHS R01 NS115860
6 · The paper itself

Abstract

Lipid rafts are highly ordered regions of the plasma membrane enriched in signaling proteins and lipids. Their biological potential is realized in exosomes, a subclass of extracellular vesicles (EVs) that originate from the lipid raft domains. Previous studies have shown that EVs derived from human placental mesenchymal stromal cells (PMSCs) possess strong neuroprotective and angiogenic properties. However, clinical translation of EVs is challenged by very low, impure, and heterogeneous yields. Therefore, in this study, lipid rafts are validated as a functional biomaterial that can recapitulate the exosomal membrane and then be synthesized into biomimetic nanovesicles. Lipidomic and proteomic analyses show that lipid raft isolates retain functional lipids and proteins comparable to PMSC-EV membranes. PMSC-derived lipid raft nanovesicles (LRNVs) are then synthesized at high yields using a facile, extrusion-based methodology. Evaluation of biological properties reveals that LRNVs can promote neurogenesis and angiogenesis through modulation of lipid raft-dependent signaling pathways. A proof-of-concept methodology further shows that LRNVs could be loaded with proteins or other bioactive cargo for greater disease-specific functionalities, thus presenting a novel type of biomimetic nanovesicles that can be leveraged as targeted therapeutics for regenerative medicine.

Indexed as

PlacentaProteomicsCell MembraneFemaleHumansLipidsMembrane MicrodomainsPregnancyProteinsLipidsProteinsangiogenesisdrug deliveryextracellular vesicleslipid raftsneuroregeneration

Identifiers

PMID36448709
PMCPMC9756296
OpenAlexW4310387984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.